Phase3, Placebo Controlled, Randomized, Double-blinded, Long-Term, NSAID-Add-on, Clinical Trial of NPC-16 for Treatment of Dysmenorrhea

Trial Profile

Phase3, Placebo Controlled, Randomized, Double-blinded, Long-Term, NSAID-Add-on, Clinical Trial of NPC-16 for Treatment of Dysmenorrhea

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Ethinylestradiol/levonorgestrel (Primary)
  • Indications Dysmenorrhoea
  • Focus Registrational; Therapeutic Use
  • Sponsors Nobelpharma
  • Most Recent Events

    • 18 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top